Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
Clinical trial NCT06966687 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06966687
- Sponsor
- Nanjing Medical University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.